Health Biotech Limited WHO-GMP
Health Biotech Limited
Health Biotech LimitedHealth Biotech Limited  
Health Biotech Limited Health Biotech Limited



pre-filled-syringes
Health Biotech Limited
Home - Oncology(Anti-Cancer-Injectables) - Leuprolide Injection

Leuprolide Injection

Category: Anti-neoplastic
Composition- : Each 0.5ml Contains : Leuprolide Acetate  1mg
Leuprolide acts as an agonist at pituitary GnRH receptors. By interrupting the normal pulsatile stimulation and the desensitization of the GnRH receptors; it indirectly down regulates the secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) leading to hypogonadism and thus a dramatic reduction in estradiol and testosterone levels in both sexes.

Specification- pH range – : 5.5 to 6.5
Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone (GnRH or LH-RH). The analog possesses greater potency than the natural hormone. It is a sterile, aqueous solution intended for subcutaneous injection.
Indication : Advanced prostatic carcinoma when orchidectomy or oestrogen administration is not indicated.
Dosage :- SC inj., 1 mg single dose.
Contraindications:- Pregnancy, in women who may become pregnant while receiving the drug, and during lactation. Sensitivity to benzyl alcohol (found in leuprolide injection). Undiagnosed abnormal vaginal bleeding. Hypersensitivity to GnRH or GnRH agonist analogs. The 30-mg depot in women.
Precautions:- Patients with metastatic vertebral lesions and/or with urinary tract obstruction should be closely observed during the first few weeks of therapy. Patients with known allergies to benzyl alcohol, an ingredient of the drug's vehicle, may present symptoms of hypersensitivity, usually local, in the form of erythema and induration at the injection site.
Drug interaction: Administration of leuprolide acetate in therapeutic doses results in suppression of the pituitary-gonadal system. Normal function is usually restored within 4 to 12 weeks after treatment is discontinued. Administration of leuprolide acetate in therapeutic doses results in suppression of the pituitary-gonadal system. Normal function is usually restored within 4 to 12 weeks after treatment is discontinued.
Adverse Effect-: High blood pressure, ischemia, insomnia, constipation, urinating more often than usual, bone pain, loss of movement in any part of your body; swelling, rapid weight gain.
Storage: : Store unopened bottles in the refrigerator. Vials can be kept at room temperature (less than 86 degrees F or 30 degrees C). Do not freeze. Protect from light.
Purity:- 99.5%
» Send Enquiry

Leuprolide-Injection
Health Biotech Limited
Our Products
Oncology(Anti-Cancer-Injectables)  |  Pre-Filled Syringes  |  Antibiotics & Anti-Infectives  |  New Molecules (FDC)  |  Liquid Ampoules / Vials  |  Biological Injections
Cardiovascular Injections  |  Neurology  |  Other Injectables  |  Hormones  |  Eye/ Ear/ Nasal Drops  |  Liquid Syrups , Dry Syrups & Redi-Mix Syrups  |  Sildenafil Oral Jelly  |  Pharmaceutical Capsules  |  Pharmaceutical Tablets  |  Tablets and Capsule


Clicky Web Analytics